LFMD LIFEMD INC

LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium

LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium on Thursday, December 14 from 10:00 a.m. – 1:00 p.m. EST. The Symposium, which LifeMD is also sponsoring, will feature experts from RWJBarnabas Health and LifeMD discussing the increasingly important and complex role of telehealth in delivering quality and timely patient care.

Anthony Puopolo, MD, President of LifeMD Affiliated P.C.s, will be serving on a panel addressing the significant value of telehealth expanding and enhancing access to quality healthcare. Eric Yecies, Chief Legal Officer & General Counsel of LifeMD, will also be serving as a panelist, addressing a variety of policy and regulatory considerations related to virtual care. RWJBarnabas Health is the largest and most comprehensive health care system in the state of New Jersey.

“At LifeMD, our entire organization is committed to using telehealth to help Americans get the quality healthcare they need, affordably and conveniently. We are proud to partner and support an organization of the quality and caliber of RWJBarnabas Health as it works to educate its providers on the importance of telemedicine,” said Justin Schreiber, Chairman and CEO, LifeMD.

The sessions include:

Expanding Access to Care: Telehealth (10:15 a.m. – 11:15 a.m. EST)

Panelists:

Neil Palmisiano, MD, Medical Oncology, RWJBarnabas Health

Frank A. Sonnenberg, MD, Internal Medicine, RWJBarnabas Health

Anthony Puopolo, MD, President, LifeMD Affiliated P.C.s

Moderator: Andy Anderson, MD, Chief Medical and Quality Officer, RWJBarnabas Health

Policies, Procedures, Regulations: Telehealth (11:45 a.m. – 12:45 p.m. EST)

Panelists:

Frank A. Sonnenberg, MD, Internal Medicine, RWJBarnabas Health

Eric Yecies, Chief Legal Officer & General Counsel, LifeMD

Moderator: Brian Dobosh, Vice President Digital Health | IT&S, RWJBarnabas Health

To register, simply click .

About LifeMD, Inc.

LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s health, women’s health, allergy & asthma, and dermatology. Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center, LifeMD is elevating healthcare by increasing access to top-notch and affordable care. For more information, please visit .

Company Contact

Marc Benathen, CFO

Media Contact

Jessica Friedeman, Chief Marketing Officer



EN
07/12/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. ...

 PRESS RELEASE

LifeMD to Participate in Two Investor Conferences During June

LifeMD to Participate in Two Investor Conferences During June NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 18. Management will participate in a virtual panel discussion titled “Direct to Consumer vs. Direct to Enterprise” at 2:00 p.m. Eastern time. Institutional investors can register for the conference by contacting their BTIG representative or by clicking . Truist Securi...

 PRESS RELEASE

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bund...

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy® Bundled Offer Includes Wegovy® at $199 and LifeMD’s Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD’s virtual weight management program. As part of it...

 PRESS RELEASE

LifeMD to Participate in Three Investor Conferences During May

LifeMD to Participate in Three Investor Conferences During May NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May: H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will be holding one-on-one meetings with investors.B. Riley Securities 25th Annual Institutional Investor Conference, May 21-22 at the Ritz-Carlton in Marina Del Rey. Management will be presenting...

 PRESS RELEASE

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Gu...

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70%Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago periodTelehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago periodGAAP net income of $0.6 million or $0.01 per diluted share, delivering first-ever quarter of positive GAAP EPSRaising full-year 2025 guidance for both total revenues and adjusted EBITDA, reflecting strong year-to-date performance in telehealth ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch